NL175882C - Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. - Google Patents
Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.Info
- Publication number
- NL175882C NL175882C NLAANVRAGE7803247,A NL175882DA NL175882C NL 175882 C NL175882 C NL 175882C NL 175882D A NL175882D A NL 175882DA NL 175882 C NL175882 C NL 175882C
- Authority
- NL
- Netherlands
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- inflammatory compound
- compound
- inflammatory
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- SRETXDDCKMOQNE-UHFFFAOYSA-N 2,3-bis(4-methoxyphenyl)-1h-indole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=CC(OC)=CC=2)C2=CC=CC=C2N1 SRETXDDCKMOQNE-UHFFFAOYSA-N 0.000 abstract 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 abstract 1
- HJKBJIYDJLVSAO-UHFFFAOYSA-L clodronic acid disodium salt Chemical compound [Na+].[Na+].OP([O-])(=O)C(Cl)(Cl)P(O)([O-])=O HJKBJIYDJLVSAO-UHFFFAOYSA-L 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 229950008443 indoxole Drugs 0.000 abstract 1
- -1 phosphonate compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78214377A | 1977-03-28 | 1977-03-28 | |
| US78214477A | 1977-03-28 | 1977-03-28 | |
| US80170777A | 1977-05-31 | 1977-05-31 | |
| US80189677A | 1977-05-31 | 1977-05-31 | |
| US80170477A | 1977-05-31 | 1977-05-31 | |
| US80189577A | 1977-05-31 | 1977-05-31 | |
| US80170577A | 1977-05-31 | 1977-05-31 | |
| SE7806449A SE441493B (sv) | 1977-03-28 | 1978-06-01 | Antiinflammatorisk komposition innefattande en salicylsyrabaserad, antiinflammatorisk forening och ett organofosfonat |
| CH601678A CH645542A5 (de) | 1977-03-28 | 1978-06-01 | Entzuendungshemmende arzneimittelpraeparate. |
| SE8001363A SE441494B (sv) | 1977-03-28 | 1980-02-21 | Antiinflammatorisk komposition innefattande en indolbaserad, antiinflammatorisk forening och ett organofosfonat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL175882C true NL175882C (nl) |
Family
ID=27579075
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7803247,A NL175882C (nl) | 1977-03-28 | Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. | |
| NLAANVRAGE7803247,A NL175882B (nl) | 1977-03-28 | 1978-03-28 | Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7803247,A NL175882B (nl) | 1977-03-28 | 1978-03-28 | Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4269828A (nl) |
| JP (1) | JPS542340A (nl) |
| AU (1) | AU524180B2 (nl) |
| BE (1) | BE865370A (nl) |
| CA (1) | CA1109794A (nl) |
| CH (1) | CH645542A5 (nl) |
| DE (1) | DE2813165C2 (nl) |
| FR (1) | FR2385398A1 (nl) |
| GB (1) | GB1588284A (nl) |
| NL (2) | NL175882B (nl) |
| SE (2) | SE441493B (nl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4602040A (en) * | 1983-04-18 | 1986-07-22 | Warner-Lambert Company | Meclofenamic acid topical pharmaceutical composition |
| CA1229554A (en) * | 1983-04-18 | 1987-11-24 | Warner-Lambert Company | Meclofenamic acid topical pharmaceutical composition |
| DE3324193A1 (de) * | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
| US4681897A (en) * | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| JPH0639449B2 (ja) * | 1989-04-10 | 1994-05-25 | エーザイ株式会社 | ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬 |
| EP0550385A1 (de) * | 1991-12-19 | 1993-07-07 | Ciba-Geigy Ag | Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten |
| DK0650361T3 (da) * | 1992-06-30 | 1999-06-23 | Procter & Gamble Pharma | Sammensætninger til behandling af arthritis, hvilke sammensætninger indeholder phosphonater og NSAID'er |
| SE9303740L (sv) * | 1993-11-12 | 1995-05-13 | Leiras Oy | Farmaceutisk komposition |
| US5652227A (en) * | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
| WO1997013519A1 (en) * | 1995-10-09 | 1997-04-17 | Russinsky Limited | Esters of cyclooxygenase inhibitors and terpene derivatives as pharmaceutical products |
| DE19615577A1 (de) * | 1996-04-19 | 1997-10-23 | Beiersdorf Ag | Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen |
| SE9703691D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Ab | Pharmaceutical compositions |
| DE10049735A1 (de) * | 2000-09-28 | 2002-04-18 | Jenapharm Gmbh | Verfahren zur Isolierung von pharmazeutisch verwertbarem Etidronat-Dinatrium |
| AUPR283801A0 (en) * | 2001-02-01 | 2001-03-01 | Australian National University, The | Chemical compounds and methods |
| AP2015008955A0 (en) | 2009-04-24 | 2015-12-31 | Icuetica Pty Ltd | A novel formulation of indomethacin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3584125A (en) * | 1968-12-23 | 1971-06-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US3553314A (en) * | 1968-12-23 | 1971-01-05 | Procter & Gamble | Oral compositions for calculus retardation |
| US3553315A (en) * | 1968-12-24 | 1971-01-05 | Procter & Gamble | Oral compositions for calculus retardation |
| US3584124A (en) * | 1968-12-24 | 1971-06-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US3678164A (en) * | 1969-02-12 | 1972-07-18 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US3641246A (en) * | 1970-01-14 | 1972-02-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phcosphate in animal tissue |
| US3662066A (en) * | 1970-03-04 | 1972-05-09 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US3683080A (en) * | 1970-08-28 | 1972-08-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| US4044125A (en) * | 1975-07-18 | 1977-08-23 | Eli Lilly And Company | Method of stabilizing acetylsalicylic acid in the presence of d-propoxyphene hydrochloride and compositions thereof |
| US4049803A (en) * | 1976-04-26 | 1977-09-20 | Bristol-Myers Company | Augmentation of blood levels of aspirin |
-
0
- NL NLAANVRAGE7803247,A patent/NL175882C/nl active
-
1978
- 1978-03-23 CA CA299,663A patent/CA1109794A/en not_active Expired
- 1978-03-24 FR FR7808745A patent/FR2385398A1/fr active Granted
- 1978-03-25 DE DE2813165A patent/DE2813165C2/de not_active Expired
- 1978-03-28 BE BE186315A patent/BE865370A/xx not_active IP Right Cessation
- 1978-03-28 NL NLAANVRAGE7803247,A patent/NL175882B/nl not_active IP Right Cessation
- 1978-03-28 GB GB12010/78A patent/GB1588284A/en not_active Expired
- 1978-03-28 AU AU34511/78A patent/AU524180B2/en not_active Expired
- 1978-03-28 JP JP3591378A patent/JPS542340A/ja active Pending
- 1978-06-01 CH CH601678A patent/CH645542A5/de not_active IP Right Cessation
- 1978-06-01 SE SE7806449A patent/SE441493B/sv not_active IP Right Cessation
- 1978-07-13 US US05/924,477 patent/US4269828A/en not_active Expired - Lifetime
-
1980
- 1980-02-21 SE SE8001363A patent/SE441494B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU524180B2 (en) | 1982-09-02 |
| CH645542A5 (de) | 1984-10-15 |
| FR2385398A1 (fr) | 1978-10-27 |
| JPS542340A (en) | 1979-01-09 |
| FR2385398B1 (nl) | 1980-04-04 |
| SE7806449L (sv) | 1979-12-02 |
| NL175882B (nl) | 1984-08-16 |
| SE8001363L (sv) | 1980-02-21 |
| DE2813165C2 (de) | 1983-12-15 |
| AU3451178A (en) | 1979-10-04 |
| US4269828A (en) | 1981-05-26 |
| CA1109794A (en) | 1981-09-29 |
| SE441494B (sv) | 1985-10-14 |
| GB1588284A (en) | 1981-04-23 |
| BE865370A (fr) | 1978-09-28 |
| DE2813165A1 (de) | 1978-10-12 |
| SE441493B (sv) | 1985-10-14 |
| NL7803247A (nl) | 1978-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL175882C (nl) | Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. | |
| NO146456C (no) | Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel | |
| NL190580B (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
| PT69922A (de) | Arzneimittel-retardform mit unloslichen porosen diffusionshullen | |
| AU4690379A (en) | Administering intravenous drugs | |
| NO863062L (no) | Innretning for administrering av medikamenter til pasienter. | |
| ATE37028T1 (de) | Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte. | |
| DK393187A (da) | Laegemiddel med antitumorvirkning | |
| IT8821543A0 (it) | Farmaci precursori della dopamina. | |
| FI812810A7 (fi) | Ammoniometyyliyhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmaseuttisia valvalmisteita ja viimemainittujen käyttö. | |
| NL193440B (nl) | Farmaceutisch preparaat met analgetische werking. | |
| BE841121A (fr) | Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques | |
| NO883500D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan. | |
| IT7922743A0 (it) | Componente di dosaggio farmaceutico a emissione controllata. | |
| DE3674040D1 (de) | Pharmazeutische zusammensetzungen. | |
| NL172157C (nl) | Preparaat met bloeddrukverlagende werking en de daarvoor geschikte werkzame verbindingen. | |
| DE3861529D1 (de) | Arzneizubereitung mit indomethacin. | |
| NL192111B (nl) | Geneesmiddelpreparaat met anti-inflammatoire werking. | |
| DK0450123T3 (da) | Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium | |
| NO891574L (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
| IT8020100A0 (it) | Medicamento, o preparato farmaceutico, ad azione citostatica. | |
| IT7822316A0 (it) | Composizione farmaceutica per la somministrazione di pancreatina. | |
| DD128671A5 (de) | Pharmazeutische mittel | |
| NO164973C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner. | |
| FR2303555A1 (fr) | Nouvel antibiotique, sa preparation et medicament le contenant |